Reevaluating Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi and for Non-Typhi Salmonellae
Open Access
- 1 July 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 75-81
- https://doi.org/10.1086/375602
Abstract
Salmonella enterica infections cause considerable morbidity and mortality worldwide. Antimicrobial therapy may be life-saving for patients with extraKeywords
This publication has 76 references indexed in Scilit:
- Life-Threatening Infantile Diarrhea from Fluoroquinolone-ResistantSalmonella entericTyphimurium with Mutations in BothgyrAandparCEmerging Infectious Diseases, 2003
- Laboratory-Based Surveillance of Salmonella Serotype Typhi Infections in the United StatesJAMA, 2000
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999
- Emergence of Multidrug-ResistantSalmonella entericaSerotypeTyphimurium DT104 Infections in the United StatesNew England Journal of Medicine, 1998
- Multidrug-Resistant Salmonella typhi: A Worldwide EpidemicClinical Infectious Diseases, 1997
- World Development Report 1996Published by World Bank ,1996
- Ciprofloxacin-resistant Salmonella typhi in the UKThe Lancet, 1995
- Summary of an International Workshop on Typhoid FeverClinical Infectious Diseases, 1986
- The problem and implications of chloramphenicol resistance in the typhoid bacillusEpidemiology and Infection, 1975
- Transferable Chloramphenicol Resistance in Salmonella typhiNature, 1972